Neurotrack Virtual Cognitive Health Study

Subjective Cognitive Decline Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02969460
• Other study ID #: EH-003
• Status: Completed
• Phase: N/A
• Start date: November 30, 2016
• Est. completion date: April 18, 2018

Study information

• Verified date: October 2018
• Source: Evidation Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The Neurotrack Virtual Cognitive Health Study is a 12-month long, prospective study that aims to evaluate the impact of the Neurotrack Virtual Cognitive Health Coaching Program on cognitive ability, anxiety and depression, and lifestyle behaviors for individuals who show signs of subjective cognitive decline.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 85
• Est. completion date: April 18, 2018
• Est. primary completion date: April 18, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 60 Years to 75 Years

Eligibility

Inclusion Criteria:

• Ages 60-75

• Individuals who show signs of subjective cognitive decline (assessed by scoring = 1 on the Subjective Cognitive Decline [Short Form] Questionnaire and endorsing the Personal Worry Item on the questionnaire)

• Have the ability to make and receive phone calls

• Have the ability to send and receive text messages

• Access to a desktop computer, video-teleconferencing and reliable internet connection

• Motivated to use a daily coaching program

Exclusion Criteria:

• Significant history of mental illness, substance abuse, learning disability, or neurologic conditions

• History of dementia

• Ophthalmologic/visual problems that prevent individual from viewing a computer screen at a normal distance (e.g., legal blindness, detached retinas, occlusive cataracts)

• Currently participating in a formal cognitive-training coaching program

• Currently pregnant

Related Conditions & MeSH terms

• Cognitive Dysfunction
• Subjective Cognitive Decline

Intervention

Behavioral:
• Neurotrack Virtual Cognitive Health Program

Locations

Country	Name	City	State
United States	Evidation Health	San Mateo	California

Sponsors (2)

Lead Sponsor	Collaborator
Evidation Health	Neurotrack

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	RBANS score	Repeatable Battery for the Assessment of Neuropsychological Status total score	week 24
Primary	RBANS score	Repeatable Battery for the Assessment of Neuropsychological Status total score	week 52
Secondary	PHQ-9	Patient-health questionnaire 9-item scale	week 24
Secondary	PHQ-9	Patient-health questionnaire 9-item scale	week 52
Secondary	GAD-7	Generalized anxiety disorder 7-item scale	week 24
Secondary	GAD-7	Generalized anxiety disorder 7-item scale	week 52